General Archives - Page 91 of 2367

2 minute read

Activist Investor Elliott Acquires Major Stake In Johnson Controls: Report

May 20, 6:24 AM

Elliott Investment Management has reportedly acquired a substantial stake in Johnson Controls International, exceeding $1 billion, ranking it among the top ten investors in the company. Despite a 9.2% rise in Johnson Controls' shares over the past year, the company's performance lags behind industry peers.

CARR

2 minute read

Tesla Price Cuts Backfiring? European Rental Companies Fume As EV Giant’s Used Car Values Plummet, Service Leaves Bad Taste

By Benzinga Neuro

May 20, 3:03 AM

This comes after fleet managers and leasing firms reported that Tesla had previously ignored these issues.

TSLA

10 minute read

Rescheduling Marijuana: How DOJ’s Action Could Transform The Industry

By Todd Harrison

May 19, 3:24 PM

By Todd Harrison via Cannabis Confidential (May 17)

GTBIG

1 minute read

Medtronic Affera Mapping And Ablation System With Sphere-9 Catheter Achieves Endpoints For Safety And Efficacy

By Benzinga Newsdesk

May 17, 4:34 PM

The Sphere-9 Catheter demonstrated a positive safety profile with an excellent primary safety endpoint rate of 1.4% (1.0% for the control arm). Importantly, no safety events including pulmonary vein stenosis, esophageal

MDT

2 minute read

We Tried ChatGPT 4: Here Are 5 Best Features From OpenAI

By Aaron Bry

May 17, 2:55 PM

The new iteration of the AI-powered chatbot is more advanced, makes less mistakes and gives users more capabilities compared to ChatGPT 3.5.

GOOGL

2 minute read

Analysts Remain Bullish on Take-Two Interactive Despite GTA VI Delay, Anticipate Strong Long-Term Growth

By Shivani Kumaresan

May 17, 2:27 PM

Take-Two Interactive Software posted strong FY4Q results, with a FY2025 net bookings outlook of $5.55-$5.65 billion. Stifel's Drew Crum noted the anticipation around GTA VI's fall 2025 launch, despite some frustration from investors. Analysts from Stifel, Benchmark, and Roth MKM reiterated their Buy ratings, with price targets ranging from $175 to $200, citing optimism for long-term growth.

TTWO

2 minute read

AbbVie Is ‘Successfully Positioned To Absorb Humira Biosimilar Erosion’: Analyst

By Vandana Singh

May 17, 1:47 PM

Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.

ABBV

1 minute read

What’s Going On With Walmart Stock Friday?

By Nabaparna Bhattacharya

May 17, 1:18 PM

Walmart inaugurates a new fulfillment center in Greencastle, enhancing fast shipping and creating over 1,000 jobs for the region.

WMT

2 minute read

Fresenius SE’s Future With Dialysis Company Unclear, Investors Seek Answers

By Vandana Singh

May 17, 1:13 PM

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and nursing shortages impact both companies' performance and share value.

BAX

1 minute read

What’s Going On With Broadcom Shares Friday?

By Nabaparna Bhattacharya

May 17, 1:08 PM

Broadcom introduces the Accelerate Program, expanding its cybersecurity offerings through exclusive agreements to enhance service levels.

AVGO